(Q34417647)

2 August 2017

1 reference

title

Prevention and management of antineoplastic-induced hypersensitivity reactions (English)

1 reference

2 August 2017

K M Zanotti

1

1 reference

PubMed ID

11676304

2 August 2017

M Markman

series ordinal

2

1 reference

2 August 2017

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

10

1 reference

2 August 2017

767-779

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200124100-00005

2 August 2017

0 references

cites work

Carboplatin hypersensitivity in children. A report of five patients with brain tumors

1 reference

12 December 2020

Hypersensitivity reactions from taxol

1 reference

12 December 2020

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

12 December 2020

Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies

1 reference

12 December 2020

Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma

1 reference

12 December 2020

VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children

1 reference

12 December 2020

Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization

1 reference

12 December 2020

Paclitaxel hypersensitivity reactions: a role for docetaxel substitution

1 reference

12 December 2020

Specific IgE antibodies to platinum salts in sensitized workers

1 reference

12 December 2020

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors.

1 reference

12 December 2020

Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

1 reference

12 December 2020

Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma

1 reference

12 December 2020

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer

1 reference

12 December 2020

Hypersensitivity and cross-reactivity to cisplatin and analogues

1 reference

12 December 2020

Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols

1 reference

12 December 2020

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group

1 reference

12 December 2020

Anaphylactic reactions to repeated intravesical instillation with cisplatin

1 reference

12 December 2020

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

1 reference

12 December 2020

Delayed allergic reactions following intramuscular L-asparaginase

1 reference

12 December 2020

Hypersensitivity reactions to teniposide (VM-26): an analysis

1 reference

12 December 2020

Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia

1 reference

12 December 2020

Intravesical cisplatin for superficial bladder tumors

1 reference

12 December 2020

Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reactions

1 reference

12 December 2020

Docetaxel: a taxoid for the treatment of metastatic breast cancer.

1 reference

12 December 2020

[New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase]

1 reference

12 December 2020

Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.

1 reference

12 December 2020

Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Rapid desensitization for L-asparaginase hypersensitivity

1 reference

12 December 2020

Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia

1 reference

12 December 2020

[Long-term infusion of L-asparaginase--an alternative to intramuscular injection?]

1 reference

12 December 2020

The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia

1 reference

12 December 2020

Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management

1 reference

12 December 2020

Hypersensitivity reactions to intraperitoneal administration of carboplatin in ovarian cancer: the first report of a case

1 reference

12 December 2020

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions

1 reference

12 December 2020

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

12 December 2020

Pretreatment of high-risk patients requiring radiographic contrast media studies.

1 reference

12 December 2020

Acute and chronic desensitization of penicillin-allergic patients using oral penicillin

1 reference

12 December 2020

A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer

1 reference

12 December 2020

Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia

1 reference

12 December 2020

Death from anaphylaxis to cisplatin: a case report

1 reference

12 December 2020

Weekly schedules of docetaxel

1 reference

12 December 2020

Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase

1 reference

12 December 2020

Coping with toxicities of docetaxel (Taxotere)

1 reference

12 December 2020

Hypersensitivity reactions

1 reference

12 December 2020

Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind

1 reference

12 December 2020

Teniposide-induced hypersensitivity reactions in children

1 reference

12 December 2020

Successful parenteral desensitization to paclitaxel

1 reference

12 December 2020

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

12 December 2020

Phase I trial of weekly paclitaxel in advanced lung cancer

1 reference

12 December 2020

1 reference

12 December 2020

Immediate hypersensitivity reactions to penicillin and related antibiotics

1 reference

12 December 2020

Immediate (type I) allergic responses to platinum compounds

1 reference

12 December 2020

Clinical features of hypersensitivity reactions to carboplatin

1 reference

12 December 2020

Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

1 reference

12 December 2020

Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma

1 reference

12 December 2020

Hypersensitivity reactions to cisplatin and carboplatin--a report on six cases

1 reference

12 December 2020

Toxicity of L-asparaginase in children with advanced leukemia

1 reference

12 December 2020

10.2165/00002018-200124100-00005

Identifiers

DOI

1 reference

PubMed ID

11676304

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11676304